Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-25-000006

Director sold 6,250 shares at an average $85.11 ($531,963)

  • Director acquired 6,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Loxam Teri Director 2025-01-15 Option exercise 10b5-1 +6,250 $22.70 $141,875 13,425 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −146 $80.46 $11,747 13,279 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −215 $81.53 $17,530 13,064 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −1,136 $82.89 $94,168 11,928 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −1,202 $83.93 $100,885 10,726 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −1,043 $85.29 $88,961 9,683 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −966 $86.26 $83,324 8,717 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −1,013 $87.38 $88,513 7,704 D
Loxam Teri Director 2025-01-15 Sale 10b5-1 −529 $88.54 $46,836 7,175 D
Derivatives
Loxam Teri Director 2025-01-15 Option exercise · Stock Option (right to buy) 10b5-1 −6,250 6,250 D
Open-market sales · 6,250 sh · avg $85.11 · $531,963
Loading xslF345X05/wk-form4_1737147935.xml…